Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Advanced Solid Tumor × balstilimab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Uterine Cervical Neoplasms 2 Advanced Solid Tumor 1

Interventions

toripalimab 5 Injections 4 tislelizumab 3 sintilimab 3 pembrolizumab 2 glumetinib 2 apatinib 2 PM 01183 2 Midazolam 2 Gemcitabine 2 Drug Therapy 2 Digoxin 2 Bupropion 2 talazoparib 1 spartalizumab 1 sonidegib 1 sitravatinib 1 serabelisib 1 rucaparib 1 repaglinide 1 penpulimab 1 palbociclib 1 lenvatinib 1 fluzoparib 1 entrectinib 1 capmatinib 1 camrelizumab 1 cabazitaxel 1 binimetinib 1 berzosertib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05377528 2025-04-30

Study of AGEN1571 in Participants With Advanced Solid Tumors

Agenus Inc.

Phase 1 Completed

Other solid neoplasm

Advanced Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡